Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Jenner

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
International Review of Neurobiology|September 13, 2011
New approaches to therapyJonathan Brotchie, Peter Jenner
Parkinsonism & Related Disorders|December 22, 2020
Can adenosine A<sub>2A</sub> receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?Tomoyuki Kanda, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2011
Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagilinePeter Jenner, J William Langston
Free Radical Biology & Medicine|February 6, 2013
Parkinson disease: from pathology to molecular disease mechanismsDavid T Dexter, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2017
Two hundred years since James Parkinson's essay on the shaking palsy-Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017K Ray Chaudhuri, Peter Jenner
Parkinsonism & Related Disorders|December 22, 2020
IntroductionPeter A LeWitt, Peter Jenner
Clinical Parkinsonism & Related Disorders|February 19, 2025
Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson's diseaseStuart H Isaacson, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2011
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulationMahmoud M Iravani, Peter Jenner
Neurology|May 24, 2006
The pathogenesis of cell death in Parkinson's diseasePeter Jenner, C Warren Olanow
Synapse (New York, N.Y.)|November 30, 2012
New directionsHenrique von Gersdorff, Peter Jenner
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
International Review of Neurobiology|September 13, 2011
New approaches to therapyJonathan Brotchie, Peter Jenner
Parkinsonism & Related Disorders|December 22, 2020
Can adenosine A<sub>2A</sub> receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease?Tomoyuki Kanda, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2011
Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagilinePeter Jenner, J William Langston
Free Radical Biology & Medicine|February 6, 2013
Parkinson disease: from pathology to molecular disease mechanismsDavid T Dexter, Peter Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2017
Two hundred years since James Parkinson's essay on the shaking palsy-Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017K Ray Chaudhuri, Peter Jenner
Parkinsonism & Related Disorders|December 22, 2020
IntroductionPeter A LeWitt, Peter Jenner
Clinical Parkinsonism & Related Disorders|February 19, 2025
Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson's diseaseStuart H Isaacson, Peter Jenner
Journal of Neural Transmission (Vienna, Austria : 1996)|September 2, 2011
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulationMahmoud M Iravani, Peter Jenner
Neurology|May 24, 2006
The pathogenesis of cell death in Parkinson's diseasePeter Jenner, C Warren Olanow
Synapse (New York, N.Y.)|November 30, 2012
New directionsHenrique von Gersdorff, Peter Jenner
Pageof 18